Skip to main content
Clinical Trials/ITMCTR1900002512
ITMCTR1900002512Not yet recruitingPhase 1

Clinical Observation and Mechanism Study for Buyang Huanwu Decoction in Improving Diabetic Peripheral Neuropathy

Hospital ( T.C.M ) Affiliated to Southwest Medical University0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • (1) those meeting the diagnostic criteria for diabetic peripheral neuropathy;
  • (2) those meeting the syndrome differentiation criteria of qi deficiency and blood stasis syndrome;
  • (3) aged between 18 and 75 (including 18 and 75);
  • (4) voluntarily participate in the study and have signed the informed consent.

Exclusion Criteria

  • (1) patients with acute complications of diabetes, such as diabetic ketosis and hyperosmolar coma;
  • (2) the neuropathy caused mental disease and other causes, such as the neck, lumbar spine lesions (nerve root compression, stenosis, neck lumbar degeneration), cerebral infarction and guillain-barre syndrome, new serious disease of heart head blood-vessel, arteriovenous vascular lesions (venous thrombosis, lymphangitis), has a motor neuropathy, alcoholism, drug especially neurotoxic effect caused by chemotherapy drugs poison and renal insufficiency caused by metabolism of nerve injury causes such as history of neuropathy;
  • (3) pregnant or lactating women or women who intend to become pregnant within the next year;
  • (4) those who are known to be allergic to the components of experimental drugs;
  • (5) those who are unable to cooperate and have participated in other clinical trials within 12 weeks prior to or before the trial.

Investigators

Sponsor
Hospital ( T.C.M ) Affiliated to Southwest Medical University

Similar Trials